DE3672628D1 - HYDANTOIN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME. - Google Patents

HYDANTOIN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.

Info

Publication number
DE3672628D1
DE3672628D1 DE8686102476T DE3672628T DE3672628D1 DE 3672628 D1 DE3672628 D1 DE 3672628D1 DE 8686102476 T DE8686102476 T DE 8686102476T DE 3672628 T DE3672628 T DE 3672628T DE 3672628 D1 DE3672628 D1 DE 3672628D1
Authority
DE
Germany
Prior art keywords
hydantoin derivatives
pharmaceutical compositions
compositions containing
production
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686102476T
Other languages
German (de)
Inventor
Kouichiro Ueda
Keiichi Nomura
Satoru Tanaka
Noboru Nakai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of DE3672628D1 publication Critical patent/DE3672628D1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Disclosed herein are hydantoin derivatives having the general formula (I) <CHEM> wherein X represents a halogen atom, and Y represents an amino or nitro group, and pharmacologically acceptable salts thereof, their preparation process and pharmaceutical compositions containing them as effective components. The hydantoin derivatives and their salts are used for the preparation of a composition for treating and preventing chronic symptoms and complications accompanying diabetes.
DE8686102476T 1985-02-26 1986-02-26 HYDANTOIN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME. Expired - Fee Related DE3672628D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60035236A JPH0772190B2 (en) 1985-02-26 1985-02-26 Hydantoin derivative

Publications (1)

Publication Number Publication Date
DE3672628D1 true DE3672628D1 (en) 1990-08-23

Family

ID=12436204

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686102476T Expired - Fee Related DE3672628D1 (en) 1985-02-26 1986-02-26 HYDANTOIN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.

Country Status (4)

Country Link
EP (1) EP0193855B1 (en)
JP (1) JPH0772190B2 (en)
AT (1) ATE54665T1 (en)
DE (1) DE3672628D1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63126881A (en) * 1986-11-14 1988-05-30 Sanwa Kagaku Kenkyusho Co Ltd Hydantoin derivative, salt and production thereof and preventing and treating agent for diabetic complication containing said compound active ingredient
EP0264586B1 (en) * 1986-08-28 1991-04-03 Sanwa Kagaku Kenkyusho Co., Ltd. Hydantoin derivatives for treating complications of diabetes
EP3551182A1 (en) 2016-12-06 2019-10-16 Topical Innovations B.V. Topical pharmaceutical composition containing phenytoin and a (co -)an algesic for the treatment of chronic pain
MA51978A (en) * 2016-12-06 2021-01-20 Hesselink Jan Marius Keppel PHENYTOIN FOR TOPICAL USE FOR USE IN THE TREATMENT OF PERIPHERAL NEUROPATHIC PAIN

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
US4464385A (en) * 1982-04-15 1984-08-07 Alcon Laboratories, Inc. Treatment of diabetic complications with hydantoins

Also Published As

Publication number Publication date
ATE54665T1 (en) 1990-08-15
EP0193855B1 (en) 1990-07-18
JPS61197581A (en) 1986-09-01
JPH0772190B2 (en) 1995-08-02
EP0193855A1 (en) 1986-09-10

Similar Documents

Publication Publication Date Title
MX9203550A (en) DERIVATIVES OF 4-AMINOQUINOLINE AND ITS USE AS MEDICINES.
ATE139232T1 (en) BIZYCLIC PYRIMIDINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
ATE150462T1 (en) PYRAZOLOPYRIDINE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
ATE25974T1 (en) ACYL-SUBSTITUTED DERIVATIVES OF 1,2,3,4TETRAHYDROISOQUINOLINE-3-CARBOXYLIC ACIDS, THEIR SALTS, MEDICATIONS CONTAINING THEM AND PROCESS FOR THEIR MANUFACTURE.
ATE40368T1 (en) XANTHINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
ATE63124T1 (en) PRODRUG COMPOUNDS, PROCESSES FOR THEIR MANUFACTURE AND DELAYED RELEASE PREPARATIONS CONTAINING THEM.
DE3882438D1 (en) ALKANSULFONANILIDE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THE PHARMACEUTICAL COMPOSITION CONTAINING THEM.
DE3676179D1 (en) N-CONTAINING HETEROCYCLIC COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THE SAME.
ATE48001T1 (en) CEPHEM COMPOUNDS, PROCESSES FOR THEIR PRODUCTION AND THEIR PHARMACEUTICAL PREPARATIONS.
ATE147625T1 (en) HYDANTOIN OR IMIDAZOLIDE INTRION DERIVATIVES FOR PREVENTING OR TREATING RENAL INSUFFICIENCY
DK562488A (en) PHARMACEUTICAL PREPARATION CONTAINING POLYMINE DERIVATIVES, AND SOME OF THESE POLYAMINE DERIVATIVES
DE3672628D1 (en) HYDANTOIN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
ATE172976T1 (en) 3-AMINOCHROMANE SPIRODERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
DK0516350T3 (en) 2-hydroxy-2-phenylethylamine derivatives as beta-3-adrenoceptor agonists
ATE214051T1 (en) SUBSTITUTED TETRAHYDROPYRIDINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING SAME
FR2694005B1 (en) New aminoalkylchromones, methods for their preparation and pharmaceutical compositions containing them.
ATE98235T1 (en) 2-THIAZOLIDINONE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM, PROCESSES FOR THEIR MANUFACTURE AND THEIR USE.
ATE40687T1 (en) NEW PYRIDE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
MA21913A1 (en) PROCESS FOR THE PREPARATION OF AMINO-OLIGOHYDROXY DERIVATIVES OF RENIN INHIBITORS.
PT81702B (en) N-SUBSTITUTED AZIRIDINE-2-CARBON SEA DERIVATIVES METHOD FOR THE PRODUCTION THEREOF AND THE MEDICAMENTS CONTAINING SUCH SUBSTANCES
ATE101119T1 (en) Butynoamides, their salts, pharmaceutical compositions containing them and processes for their preparation.
ATE140216T1 (en) (CYCLOHEXYL)ALKENE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE3577316D1 (en) AMINOMETHYL-6-FURO (3,4-C) PYRIDINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
ES8801291A1 (en) Cephalosporins, processes for their preparation and pharmaceutical compositions containing them.
DE69011174D1 (en) Catecholamine ester.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee